Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners

Objectives Ocular pain is a commonly reported finding in the intravitreal injection procedure, but post-injection experiences and patient adherence to treatment remain underexplored. We therefore aimed to identify key variations in the intravitreal injection procedure that may influence pain, and to...

Full description

Bibliographic Details
Main Authors: Heather Waterman, Sanjiv Banerjee, Christina Yiallouridou, Jennifer H Acton, Ashley Wood
Format: Article
Language:English
Published: BMJ Publishing Group 2023-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/8/e069625.full
_version_ 1797740947600048128
author Heather Waterman
Sanjiv Banerjee
Christina Yiallouridou
Jennifer H Acton
Ashley Wood
author_facet Heather Waterman
Sanjiv Banerjee
Christina Yiallouridou
Jennifer H Acton
Ashley Wood
author_sort Heather Waterman
collection DOAJ
description Objectives Ocular pain is a commonly reported finding in the intravitreal injection procedure, but post-injection experiences and patient adherence to treatment remain underexplored. We therefore aimed to identify key variations in the intravitreal injection procedure that may influence pain, and to gain insights into the post-injection experience and treatment adherence from the perspective of patients and practitioners.Design Qualitative semistructured interview study using reflexive thematic analysis of transcripts.Setting Hospital Eye Clinic in Wales, UK. Interviews were conducted between May and September 2019.Participants Purposive sample of patients aged ≥50 years with neovascular age-related macular degeneration and no other retinal pathology who had received at least six intravitreal injections, and practitioners including ophthalmologists, registered nurses and optometrists who performed intravitreal injections at the research site.Results Data saturation was reached with 21 interviews: 14 patients and 7 practitioners. Three main themes were identified from the analysis: fear of losing eyesight and treatment anxiety influence patient adherence to treatment, variability in pain experience during treatment, and post-injection experience and impact on patient recovery. To reassure patients feeling apprehensive about the injections, practitioners promoted safety and trust, and used techniques to manage anxiety. Key variations that may influence pain identified were application of antiseptic or anaesthetic, injecting methods and communication. During injection, patients reported a dull-aching and sharp pain, contrary to practitioners’ perspective of feeling a ‘pressure’. Patients described prolonged soreness and irritation of up to 36 hours post-injection affecting their sleep and recovery.Conclusion Establishing rapport supported patients to recognise the necessity of ongoing treatment to prevent sight loss; however, inadequate pain management led to undesirable outcomes. Practitioners should use pain assessment tools during and immediately after injection and provide ongoing consistent information to help patients manage pain at home.
first_indexed 2024-03-12T14:19:47Z
format Article
id doaj.art-b3c3539530d74d71977e3b37f40ac0d5
institution Directory Open Access Journal
issn 2044-6055
language English
last_indexed 2024-03-12T14:19:47Z
publishDate 2023-08-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj.art-b3c3539530d74d71977e3b37f40ac0d52023-08-19T11:20:08ZengBMJ Publishing GroupBMJ Open2044-60552023-08-0113810.1136/bmjopen-2022-069625Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitionersHeather Waterman0Sanjiv Banerjee1Christina Yiallouridou2Jennifer H Acton3Ashley Wood43 Healthcare Sciences, Cardiff University, Cardiff, UK2 Ophthalmology, Cardiff and Vale University Health Board, Cardiff, UK1 School of Optometry and Vision Sciences, Cardiff University, Cardiff, UK1 School of Optometry and Vision Sciences, Cardiff University, Cardiff, UK1 School of Optometry and Vision Sciences, Cardiff University, Cardiff, UKObjectives Ocular pain is a commonly reported finding in the intravitreal injection procedure, but post-injection experiences and patient adherence to treatment remain underexplored. We therefore aimed to identify key variations in the intravitreal injection procedure that may influence pain, and to gain insights into the post-injection experience and treatment adherence from the perspective of patients and practitioners.Design Qualitative semistructured interview study using reflexive thematic analysis of transcripts.Setting Hospital Eye Clinic in Wales, UK. Interviews were conducted between May and September 2019.Participants Purposive sample of patients aged ≥50 years with neovascular age-related macular degeneration and no other retinal pathology who had received at least six intravitreal injections, and practitioners including ophthalmologists, registered nurses and optometrists who performed intravitreal injections at the research site.Results Data saturation was reached with 21 interviews: 14 patients and 7 practitioners. Three main themes were identified from the analysis: fear of losing eyesight and treatment anxiety influence patient adherence to treatment, variability in pain experience during treatment, and post-injection experience and impact on patient recovery. To reassure patients feeling apprehensive about the injections, practitioners promoted safety and trust, and used techniques to manage anxiety. Key variations that may influence pain identified were application of antiseptic or anaesthetic, injecting methods and communication. During injection, patients reported a dull-aching and sharp pain, contrary to practitioners’ perspective of feeling a ‘pressure’. Patients described prolonged soreness and irritation of up to 36 hours post-injection affecting their sleep and recovery.Conclusion Establishing rapport supported patients to recognise the necessity of ongoing treatment to prevent sight loss; however, inadequate pain management led to undesirable outcomes. Practitioners should use pain assessment tools during and immediately after injection and provide ongoing consistent information to help patients manage pain at home.https://bmjopen.bmj.com/content/13/8/e069625.full
spellingShingle Heather Waterman
Sanjiv Banerjee
Christina Yiallouridou
Jennifer H Acton
Ashley Wood
Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners
BMJ Open
title Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners
title_full Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners
title_fullStr Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners
title_full_unstemmed Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners
title_short Pain related to intravitreal injections for age-related macular degeneration: a qualitative study of the perspectives of patients and practitioners
title_sort pain related to intravitreal injections for age related macular degeneration a qualitative study of the perspectives of patients and practitioners
url https://bmjopen.bmj.com/content/13/8/e069625.full
work_keys_str_mv AT heatherwaterman painrelatedtointravitrealinjectionsforagerelatedmaculardegenerationaqualitativestudyoftheperspectivesofpatientsandpractitioners
AT sanjivbanerjee painrelatedtointravitrealinjectionsforagerelatedmaculardegenerationaqualitativestudyoftheperspectivesofpatientsandpractitioners
AT christinayiallouridou painrelatedtointravitrealinjectionsforagerelatedmaculardegenerationaqualitativestudyoftheperspectivesofpatientsandpractitioners
AT jenniferhacton painrelatedtointravitrealinjectionsforagerelatedmaculardegenerationaqualitativestudyoftheperspectivesofpatientsandpractitioners
AT ashleywood painrelatedtointravitrealinjectionsforagerelatedmaculardegenerationaqualitativestudyoftheperspectivesofpatientsandpractitioners